alovudine has been researched along with Disease Models, Animal in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (33.33) | 29.6817 |
| 2010's | 19 (57.58) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Kuge, Y; Matsuda, T; Nakajima, K; Ogawa, M; Suzuki, M; Yokouchi, Y | 1 |
| Dweck, MR; Fletcher, AJ; Syed, MBJ | 1 |
| Ashek, A; Boellaard, R; Bogaard, HJ; Botros, L; Cupitt, J; Dabral, S; de Man, FS; Dubois, O; Frings, V; Harms, HJ; Huisman, MC; Jansen, S; Lammertsma, AA; Pullamsetti, SS; Spruijt, OA; Vonk Noordegraaf, A; Wharton, J; Wilkins, MR; Zhao, L | 1 |
| Babur, M; Brown, G; Burrows, N; Cawthorne, C; Dive, C; Forster, D; Gieling, RG; Gregory, J; Hiscock, D; Hodgkinson, C; McMahon, A; Morrow, CJ; Radigois, M; Simpson, K; Smigova, A; Williams, KJ; Wilson, I | 1 |
| Björkling, F; Erichsen, KD; Højgaard, L; Jensen, MM; Jensen, PB; Johnbeck, CB; Kjær, A; Madsen, J; Sehested, M | 1 |
| Ayers, GD; Coffey, RJ; Manning, HC; McKinley, ET; Saleh, SA; Smith, RA; Washington, MK; Zhao, P | 1 |
| Chung, JH; Hong, IK; Kim, DY; Kim, SY; Kim, TW; Lee, SJ; Moon, DH; Oh, J; Oh, SJ; Ryu, JS | 1 |
| Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G | 1 |
| Brekke, N; Fonnes, T; Haldorsen, IS; Kopperud, R; Krakstad, C; McCormack, E; Pavlin, T; Popa, M; Rygh, CB; Salvesen, HB; Visser, NC | 1 |
| Belanger, AP; Binderup, T; Calcagno, C; Courties, G; Di Carli, MF; Dubey, S; Fayad, ZA; Ishino, S; Iwamoto, Y; Johnbeck, CB; Keliher, EJ; Kjaer, A; Knigge, U; Libby, P; Mani, V; Mulder, WJ; Nahrendorf, M; Pérez-Medina, C; Swirski, FK; Tang, J; Tawakol, A; Weissleder, R; Wojtkiewicz, GR; Ye, YX | 1 |
| Pauwels, P; Rapic, S; Staelens, S; Stroobants, S; Thomae, D; Van den Wyngaert, T; Vangestel, C; Verhaeghe, J | 1 |
| Faber, C; Griffiths, JR; Heinzmann, K; Held, A; Hermann, S; Honess, DJ; Jacobs, AH; Schelhaas, S; Smith, DM; Wachsmuth, L | 1 |
| Dence, CS; Lewis, JS; Ponde, DE; Welch, MJ | 1 |
| Buck, AK; Dechow, T; Herrmann, K; Schwaiger, M; Shen, C; Wester, HJ | 1 |
| Anderson, C; Babusis, D; Hawkins, MJ; Henne, IN; Jeraj, R; Kurzman, ID; Lawrence, J; Plaza, S; Ray, AS; Reiser, H; Robat, C; Thamm, DH; Tumas, DB; Vail, DM; Vanderhoek, M; Watkins, WJ; Wessel, MA; Wolfgang, GH | 1 |
| Choi, SJ; Im, KC; Kim, JS; Kim, SJ; Kim, SW; Kim, SY; Lee, JS; Lee, SJ; Moon, DH; Oh, SJ; Park, SA; Ryu, JS; Yun, SC | 1 |
| Aide, N; Cullinane, C; Dorow, D; Hicks, RJ; Kinross, K; McArthur, G; Neels, O; Roselt, P; Waldeck, K | 1 |
| Dence, C; Fujibayashi, Y; Hasegawa, Y; Kiyono, Y; Kobayashi, M; Oyama, N; Ponde, DE; Welch, MJ; Yokoyama, O | 1 |
| Björkling, F; Erichsen, KD; Højgaard, L; Jensen, MM; Jensen, PB; Kjær, A; Madsen, J; Sehested, M | 1 |
| Arango, ME; Binns, D; Bogatyreva, E; Christensen, JG; Cullinane, C; Dorow, DS; Hicks, RJ; Jackson, S; McArthur, GA; Solomon, B; Young, R | 1 |
| Affolter, T; Buckman, D; Christensen, JG; Cullinane, C; Fahey, NR; Kuszpit, K; Lappin, PB; Li, W; Lira, ME; Nichols, T; O'Brien, P; Painter, CL; Spilker, M; Wong, A; Yan, Z; Zasadny, K; Zhang, CC; Zhang, Q | 1 |
| Eichner, M; Föller, M; Fuchs, K; Kneilling, M; Kukuk, D; Lang, F; Pichler, BJ; Reischl, G; Reutershan, J; Röcken, M | 1 |
| Backes, H; Fink, GR; Graf, R; Hoehn, M; Jantzen, SU; Muesken, S; Neumaier, B; Rueger, MA; Schnakenburg, K; Schroeter, M; Walberer, M | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
| Chan, PC; Chou, LS; Ho, CH; Lin, MH; Lin, WJ; Liu, RS; Shen, CC; Wang, HE; Wu, CY | 1 |
| Bangerter, M; Bommer, M; Buck, A; Leithäuser, F; Munzert, G; Neumaier, B; Reske, SN; Schultheiss, S; Seitz, U; Wagner, M; Wawra, E | 1 |
| Cobben, DC; de Vries, EF; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van Waarde, A | 1 |
| Barrio, J; Czernin, J; Halpern, BS; Mellinghoff, IK; Phelps, ME; Rozengurt, N; Safaei, A; Satyamurthy, N; Sawyers, CL; Silverman, DH; Stout, D; Tran, C; Waldherr, C; Weber, WA | 1 |
| Deisenhofer, S; Reske, SN | 1 |
| Chao, KS | 1 |
| Atkinson, DM; Carlson, BL; Clarke, MJ; Jacobson, MS; Kemp, BJ; Lowe, VJ; Mladek, AC; Sarkaria, JN; Trump, DP | 1 |
| Bradbury, MS; Burnazi, EM; Cai, S; Hambardzumyan, D; Holland, EC; Larson, SM; Longo, V; Schwartz, J; Zanzonico, PB | 1 |
33 other study(ies) available for alovudine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
PD1 blockade alters cell-cycle distribution and affects 3'-deoxy-3'-[
Topics: Animals; Cell Division; Cell Line, Tumor; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Interferons; Interleukin-2; Mice; Receptors, Death Domain; Thymidine; Tumor Necrosis Factor-alpha | 2022 |
Imaging cellular activity and proliferation in the aortic wall.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Fluorine Radioisotopes; Male; Mice; Mice, Knockout, ApoE; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Time Factors | 2021 |
3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
Topics: Adult; Aged; Animals; Case-Control Studies; Cell Proliferation; Cells, Cultured; Dideoxynucleosides; Disease Models, Animal; Equilibrative Nucleoside Transporter 1; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Humans; Ki-67 Antigen; Lung; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Predictive Value of Tests; Pulmonary Artery; Radiopharmaceuticals; Rats, Sprague-Dawley; Thymidine Kinase; Thymidine Phosphorylase; Vascular Remodeling | 2018 |
[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dideoxynucleosides; Disease Models, Animal; Female; HCT116 Cells; Humans; Indazoles; Mice; Neoplasm Metastasis; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Positron-Emission Tomography; Signal Transduction; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice.
Topics: Animals; Antineoplastic Agents; Dideoxynucleosides; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hydroxamic Acids; Ki-67 Antigen; Mice; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonamides; Thymidine Kinase; Tumor Burden | 2013 |
Limits of [18F]-FLT PET as a biomarker of proliferation in oncology.
Topics: Animals; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; HCT116 Cells; Humans; Immunohistochemistry; Mice; Mutation; Neoplasms; Positron-Emission Tomography; Thymidine; Transplantation, Heterologous | 2013 |
3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging of thymidine kinase 1 activity after 5-fluorouracil treatment in a mouse tumor model.
Topics: Animals; Colonic Neoplasms; Dideoxynucleosides; Disease Models, Animal; Fluorouracil; Heterografts; HT29 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Positron-Emission Tomography; Thymidine Kinase; Thymidylate Synthase | 2014 |
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Topics: Aged; Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Dideoxynucleosides; Disease Models, Animal; Disease Progression; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Bone Marrow; Carotid Artery Diseases; Cell Proliferation; Cholesterol, Dietary; Dideoxynucleosides; Diet, High-Fat; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cells; Humans; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Retrospective Studies; Spleen; Time Factors; Tomography, X-Ray Computed | 2015 |
Evaluation of [
Topics: Adenosine Triphosphate; Animals; Biomarkers, Tumor; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Disease Models, Animal; Female; Immunohistochemistry; Kinetics; Mice, Nude; Reproducibility of Results; Thymidine; Thymidine Kinase | 2017 |
Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Deoxycytidine; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Female; Flow Cytometry; Gemcitabine; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2016 |
Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
Topics: Animals; Autoradiography; Cell Line, Tumor; Coordination Complexes; Copper Radioisotopes; Dideoxynucleosides; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gliosarcoma; Humans; Metabolic Clearance Rate; Misonidazole; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thiosemicarbazones; Tissue Distribution | 2008 |
Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.
Topics: Animals; Cell Proliferation; Clinical Trials as Topic; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Molecular Diagnostic Techniques; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
Topics: Alanine; Animals; Animals, Domestic; Anorexia; Antineoplastic Agents; Area Under Curve; Diarrhea; Dideoxynucleosides; Disease Models, Animal; Dog Diseases; Dogs; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Nausea; Positron-Emission Tomography; Purines; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss | 2009 |
Reproducibility of the kinetic analysis of 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography in mouse tumor models.
Topics: Animals; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; Disease Models, Animal; Humans; Kinetics; Male; Mice; Observer Variation; Positron-Emission Tomography; Reproducibility of Results | 2009 |
18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Dideoxynucleosides; Disease Models, Animal; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome | 2010 |
Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Immunohistochemistry; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Time Factors; Treatment Outcome | 2011 |
Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2010 |
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
Topics: Animals; Biomarkers; Cell Line, Tumor; Cell Proliferation; Crizotinib; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasm Transplantation; Piperidines; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Signal Transduction | 2011 |
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Proliferation; Cyclin-Dependent Kinases; Dideoxynucleosides; Disease Models, Animal; Humans; Mice; Mice, Nude; Mice, SCID; Neoplasms; Piperazines; Positron-Emission Tomography; Pyridines; Thymidine; Xenograft Model Antitumor Assays | 2012 |
Oxygen breathing affects 3'-deoxy-3'-18F-fluorothymidine uptake in mouse models of arthritis and cancer.
Topics: Anesthesia; Animals; Ankle; Arthritis; Artifacts; Biological Transport; Carbon Dioxide; Cell Line, Tumor; Colonic Neoplasms; Consciousness; Dideoxynucleosides; Disease Models, Animal; Female; Glucose-6-Phosphate Isomerase; Ketamine; Lactic Acid; Mice; Mice, Inbred BALB C; Oxygen; Positron-Emission Tomography; Respiration; Xylazine | 2012 |
Effects of minocycline on endogenous neural stem cells after experimental stroke.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Bacterial Agents; Brain Infarction; Brain Mapping; Bromodeoxyuridine; Carbon Isotopes; CD11b Antigen; Cell Differentiation; Cell Proliferation; Cell Survival; Dideoxynucleosides; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Encephalitis; Glial Fibrillary Acidic Protein; Infarction, Middle Cerebral Artery; Intermediate Filament Proteins; Isoquinolines; Magnetic Resonance Imaging; Male; Minocycline; Nerve Tissue Proteins; Nestin; Neural Stem Cells; Positron-Emission Tomography; Rats; Rats, Wistar; Time Factors; Tubulin | 2012 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
Monitoring tumor response with radiolabeled nucleoside analogs in a hepatoma-bearing mouse model early after doxisome(®) treatment.
Topics: Animals; Bromodeoxycytidine; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Death; Deoxycytidine; Dideoxynucleosides; Disease Models, Animal; Doxorubicin; Endocytosis; Hep G2 Cells; Humans; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Multimodal Imaging; Polyethylene Glycols; Positron-Emission Tomography; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.
Topics: Animals; Cell Division; Dideoxynucleosides; Disease Models, Animal; Fluorine Radioisotopes; Humans; Lymphoma, B-Cell; Mice; Mice, SCID; Neoplasm Transplantation; Pilot Projects; Radiopharmaceuticals; Thymidine Kinase; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Inflammation; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Rodentia; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2004 |
Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Mice, SCID; Neoplasm Invasiveness; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Treatment Outcome | 2005 |
Is 3'-deoxy-3'-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?
Topics: Animals; Antineoplastic Agents; Dideoxynucleosides; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Neoplasms; Radionuclide Imaging; Reproducibility of Results | 2006 |
3'-deoxy-3'-(18)F-fluorothymidine (FLT) positron emission tomography for early prediction of response to chemoradiotherapy--a clinical application model of esophageal cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Docetaxel; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Mice; Neoadjuvant Therapy; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Remission Induction; Taxoids; Treatment Outcome | 2007 |
Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Dideoxynucleosides; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines | 2008 |
Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas.
Topics: Animals; Brain Neoplasms; Dideoxynucleosides; Disease Models, Animal; Glioma; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Knockout; Mice, Transgenic; Positron-Emission Tomography; Tissue Distribution | 2008 |